Logo image
Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study
Journal article   Open access   Peer reviewed

Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study

Sarah Ennis, Catherine Jomary, Robert Mullins, Angela Cree, Xiaoli Chen, Alex Macleod, Stephen Jones, Andrew Collins, Edwin Stone and Andrew Lotery
The Lancet (British edition), Vol.372(9652), pp.1828-1834
11/22/2008
DOI: 10.1016/S0140-6736(08)61348-3
PMCID: PMC5983350
PMID: 18842294
url
https://doi.org/10.1016/S0140-6736(08)61348-3View
Published (Version of record) Open Access

Abstract

Age-related macular degeneration is the most prevalent form of visual impairment and blindness in developed countries. Genetic studies have made advancements in establishing the molecular cause of this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome 10 encompassing the HTRA1/LOC387715/ARMS2 genes. Variants in complement 3 (C3) and an HLA locus containing both factor B and C2 genes have also been implicated. We aimed to identify further genetic risk factors for this disease. We used a case-control study design in a UK sample of patients with age-related macular degeneration (n=479) and controls (n=479) and undertook a low-density screen of 32 genes using 93 single nucleotide polymorphisms (SNPs). Genes were selected as candidates on the basis of potential functional relevance to age-related macular degeneration. Significant initial findings were confirmed by replication in an independent US cohort of 248 unrelated patients with disease and 252 controls, and by high-density genotyping around association signals. The SNP variant rs2511989, located within intron six of the SERPING1 gene, showed highly significant genotypic association with age-related macular degeneration (uncorrected p=4.0x10(-5), corrected p=0.00372). We detected no evidence for association between disease and the other 31 candidate genes. The odds ratio for age-related macular degeneration in rs2511989 G/A heterozygotes compared with wild type G/G homozygotes was 0.63 (95% CI 0.47-0.84). A similar comparison of the A/A homozygotes with the wild type yielded an odds ratio of 0.44 (0.31-0.64). We replicated the observed genotypic association in a US cohort (p=0.008). Furthermore, a secondary high-density genotyping study across the SERPING1 gene region identified five additional SNP variants similarly associated with age-related macular degeneration (rs2244169, rs2511990, rs2509897, rs1005510, and rs2511988). Genetic variation in SERPING1 significantly alters susceptibility to age-related macular degeneration. SERPING1 encodes the C1 inhibitor, which has a crucial role in inhibition of complement component 1 (C1) and might implicate the classic pathway of complement activation in this disease.
United Kingdom Humans Middle Aged Genotype Male Complement C1 Inhibitor Protein Case-Control Studies Complement C1 Inactivator Proteins - genetics Macular Degeneration - genetics Aged, 80 and over Polymorphism, Single Nucleotide - genetics Female Aged

Details

Metrics

28 Record Views
Logo image